ESC

ESC
  • 文章类型: Journal Article
    伊塔鲁里爱德华氏杆菌是革兰氏阴性,兼性细胞内细菌,可引起cat鱼(ESC)的肠败血症。RNA分子伴侣Hfq(噬菌体Qβ复制的宿主因子)通过各种病原细菌中的小RNA(sRNA)促进基因调控。尽管它在其他细菌物种中具有重要意义,hfq在伊塔卢里的作用仍未被探索。这项研究旨在通过框内基因缺失和表征来创建hfq突变体(EiΔhfq),从而阐明hfq在E.ictaluri中的作用。我们的发现表明,Hfq蛋白在爱德华氏菌属中高度保守。hfq的缺失导致在指数后期的生长速率显著降低。此外,EiΔhfq显示出生物膜形成的能力降低,并显示出增加的运动性。在酸性和氧化应激条件下,EiΔhfq显示生长受损,当受到体外和体内应激条件时,我们观察到hfq表达升高。EiΔhfq在cat鱼腹膜巨噬细胞内显示出降低的存活率,尽管它对上皮细胞的粘附和侵袭没有明显的影响。感染模型显示,cat鱼的细菌持久性需要hfq,并且它的缺失导致cat鱼的毒力显着减弱。最后,EiΔhfq疫苗完全保护鲶鱼免受随后的EiWT感染。总之,这些结果强调了hfq在伊氏大肠杆菌中的关键作用,影响它的成长,运动性,生物膜的形成,应激反应,以及巨噬细胞和鲶鱼宿主内的毒力。
    Edwardsiella ictaluri is a Gram-negative, facultative intracellular bacterium that causes enteric septicemia in catfish (ESC). The RNA chaperone Hfq (host factor for phage Qβ replication) facilitates gene regulation via small RNAs (sRNAs) in various pathogenic bacteria. Despite its significance in other bacterial species, the role of hfq in E. ictaluri remains unexplored. This study aimed to elucidate the role of hfq in E. ictaluri by creating an hfq mutant (EiΔhfq) through in-frame gene deletion and characterization. Our findings revealed that the Hfq protein is highly conserved within the genus Edwardsiella. The deletion of hfq resulted in a significantly reduced growth rate during the late exponential phase. Additionally, EiΔhfq displayed a diminished capacity for biofilm formation and exhibited increased motility. Under acidic and oxidative stress conditions, EiΔhfq demonstrated impaired growth, and we observed elevated hfq expression when subjected to in vitro and in vivo stress conditions. EiΔhfq exhibited reduced survival within catfish peritoneal macrophages, although it had no discernible effect on the adherence and invasion of epithelial cells. The infection model revealed that hfq is needed for bacterial persistence in catfish, and its absence caused significant virulence attenuation in catfish. Finally, the EiΔhfq vaccination completely protected catfish against subsequent EiWT infection. In summary, these results underscore the pivotal role of hfq in E. ictaluri, affecting its growth, motility, biofilm formation, stress response, and virulence in macrophages and within catfish host.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    细胞衰老(CS)被认为是衰老的标志之一,也是各种与年龄有关的疾病的重要参与者。衰老细胞的积累可以促进促炎和促癌微环境。在潜在的感官疗法是细胞外囊泡(EV)(40-1000nm),包括外泌体(40-150nm),在小区通信中起着重要作用。这里,我们回顾了关于干细胞衍生的电动汽车影响的最新研究(MSCs,ESC,iPSCs)以及CS上各种类型的非干细胞,并讨论了负责EV的感官治疗作用的潜在机制。分析显示(i)源自干细胞的电动汽车,多能性(ESC,iPSC)或多能(各种来源的MSC),可以在体外和体内减轻细胞衰老表型;(ii)这种作用可能是衰老的;(iii)电动汽车显示跨物种活动,没有明显的免疫原性反应。总之,干细胞衍生的电动汽车似乎是有前途的感官疗法,在人类中的可行应用。
    Cellular senescence (CS) is recognized as one of the hallmarks of aging, and an important player in a variety of age-related pathologies. Accumulation of senescent cells can promote a pro-inflammatory and pro-cancerogenic microenvironment. Among potential senotherapeutics are extracellular vesicles (EVs) (40-1000 nm), including exosomes (40-150 nm), that play an important role in cell-cell communications. Here, we review the most recent studies on the impact of EVs derived from stem cells (MSCs, ESCs, iPSCs) as well as non-stem cells of various types on CS and discuss potential mechanisms responsible for the senotherapeutic effects of EVs. The analysis revealed that (i) EVs derived from stem cells, pluripotent (ESCs, iPSCs) or multipotent (MSCs of various origin), can mitigate the cellular senescence phenotype both in vitro and in vivo; (ii) this effect is presumably senomorphic; (iii) EVs display cross-species activity, without apparent immunogenic responses. In summary, stem cell-derived EVs appear to be promising senotherapeutics, with a feasible application in humans.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的提供欧洲心脏病学会(ESC)和美国心脏病学会/美国心脏协会(ACC/AHA)指南之间心脏MRI适应症的全面头对头比较和时间分析,以确定共识和分歧的领域。材料与方法进行系统评价和荟萃分析。直到2023年5月发布的ESC和ACC/AHA指南对与心脏MRI相关的建议进行了系统筛选。使用χ2或Fisher精确检验比较了两个指南之间以及每个指南的较新版本与较旧版本之间的心脏MRI建议的建议类别(COR)和证据水平(LOE)。结果ESC指南包括109条关于心脏MRI的建议,行政协调会/AHA准则包括90项建议。ACC/AHA指南中CORI和LOEB的比例高于ESC指南(60%[54/90]对46.8%[51/109];P=.06和53%[48/90]对35.8%[39/109],分别为;P=0.01)。随着时间的推移,ESC指南中心脏MRI推荐数量的增加显着增加(ESC从63到109,ACC/AHA从65到90;P=0.03)。达成共识的主要领域是心力衰竭和肥厚型心肌病,虽然主要的分歧是瓣膜性心脏病,心律失常,和主动脉疾病。结论ESC指南包括更多与心脏MRI使用相关的建议,而ACC/AHA建议的COR和LOE较高。在两个指南中,心脏MRI建议的数量随着时间的推移显著增加,表明心脏MRI评估和治疗心血管疾病的作用日益增强。关键词:心血管磁共振,Guideline,欧洲心脏病学会,ESC,美国心脏病学会/美国心脏协会,ACC/AHA补充材料可用于本文。©RSNA,2024.
    Purpose To provide a comprehensive head-to-head comparison and temporal analysis of cardiac MRI indications between the European Society of Cardiology (ESC) and American College of Cardiology/American Heart Association (ACC/AHA) guidelines to identify areas of consensus and divergence. Materials and Methods A systematic review and meta-analysis was conducted. ESC and ACC/AHA guidelines published until May 2023 were systematically screened for recommendations related to cardiac MRI. The class of recommendation (COR) and level of evidence (LOE) for cardiac MRI recommendations were compared between the two guidelines and between newer versus older versions of each guideline using χ2 or Fisher exact tests. Results ESC guidelines included 109 recommendations regarding cardiac MRI, and ACC/AHA guidelines included 90 recommendations. The proportion of COR I and LOE B was higher in ACC/AHA versus ESC guidelines (60% [54 of 90] vs 46.8% [51 of 109]; P = .06 and 53% [48 of 90] vs 35.8% [39 of 109], respectively; P = .01). The increase in the number of cardiac MRI recommendations over time was significantly higher in ESC guidelines (from 63 to 109 for ESC vs from 65 to 90 for ACC/AHA; P = .03). The main areas of consensus were found in heart failure and hypertrophic cardiomyopathy, while the main divergences were in valvular heart disease, arrhythmias, and aortic disease. Conclusion ESC guidelines included more recommendations related to cardiac MRI use, whereas the ACC/AHA recommendations had higher COR and LOE. The number of cardiac MRI recommendations increased significantly over time in both guidelines, indicating the increasing role of cardiac MRI evaluation and management of cardiovascular disease. Keywords: Cardiovascular Magnetic Resonance, Guideline, European Society of Cardiology, ESC, American College of Cardiology/American Heart Association, ACC/AHA Supplemental material is available for this article. © RSNA, 2024.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Escutinetin(Esc),一种用于中药的香豆素衍生物和草药化合物,是从白蜡中提取的。Esc在抑制增殖方面显示出显著的潜力,各种癌细胞系的转移和细胞周期停滞。本综述基于Esc在癌症领域的研究文章,2009年至2023年出版。这些研究一致证明,Esc可以通过多种机制有效抑制癌细胞增殖,调节多种信号通路,如Wnt/β-catenin,PI3K/Akt,MAPK和janus激酶/信号转导子和转录激活因子-3。此外,Esc的安全性已在可靠的动物实验中得到证明,这表明Esc是一种有效的化合物。此外,Esc与常用化疗药物的联合治疗前景广阔。本综述的目的是鼓励Esc在癌症治疗中的进一步研究和应用。
    Esculetin (Esc), a coumarin derivative and herbal medicinal compound used in traditional Chinese medicine, is extracted from Fraxinus chinensis. Esc has shown notable potential in the inhibition of proliferation, metastasis and cell cycle arrest in various cancer cell lines. The present review is based on research articles regarding Esc in the field of carcinoma, published between 2009 and 2023. These studies have unanimously demonstrated that Esc can effectively inhibit cancer cell proliferation through diverse mechanisms and modulate multiple signaling pathways, such as Wnt/β-catenin, PI3K/Akt, MAPK and janus kinase/signal transducer and activator of transcription-3. In addition, the safety profile of Esc has been demonstrated in credible animal experiments, which has indicated Esc as an effective compound. Furthermore, the combination therapy of Esc with commonly used chemotherapeutic drugs holds great promise. The aim of the present review was to encourage further studies and applications of Esc in cancer therapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:表面清洁和消毒是打破传播链并降低医疗保健相关感染(HAI)风险的关键部分。然而,如果清洁和消毒剂配方与表面材料不相容,由于环境应力开裂(ESC),频繁的应用会导致塑料过早失效。选择清洁和消毒产品时应考虑材料的相容性。
    目的:这项研究评估了2合1湿巾在常见的保健塑料中引起ESC的趋势。
    方法:根据BSENISO-22088-3,评估了八种即用型2合1湿巾在13种塑料表面引起ESC的能力。将聚合物暴露于从湿巾中提取的液体中,固定应变为0.5%,持续7天,并评估其开裂情况。crazing,和拉伸强度符合ISO527-2:2012。
    结果:所有测试的2合1湿巾均含有ESC剂,尽管ESC的严重程度各不相同。pH值较高(>8.0)的产品导致了74%的故障,39个测试塑料中有22个明显开裂。尽管所有测试的擦拭制剂中的主要活性成分是季铵化合物(QAC),包含小/中等胺或醇的制剂显示出更大的塑料开裂倾向。
    结论:每种消毒剂制剂都表现出独特的微生物功效谱和导致表面损伤的独特潜力。这可能导致可能危及患者和工作人员安全的设备故障和召回。BSENISO-22088-3可以支持消毒剂和洗涤剂产品上市前的材料相容性评估。
    BACKGROUND: Surface cleaning and disinfection is a key part of breaking the chain of transmission and reducing the risk of healthcare associated infections. However, if cleaning and disinfectant formulations are incompatible with surface materials, frequent application can cause premature failure of plastics due to environmental stress cracking (ESC). Material compatibility should be considered when selecting cleaning and disinfecting products.
    OBJECTIVE: This study evaluated the tendency of 2-in-1 wet wipes to cause ESC in commonly found healthcare plastics.
    METHODS: Eight ready-to-use 2-in-1 wet wipes were evaluated for their ability to cause ESC in 13 plastic surfaces in accordance with BS EN ISO-22088-3. Polymers were exposed to fluid extracted from wipes at a fixed strain of 0.5% for seven days and assessed for cracking, crazing, and tensile strength in accordance with ISO 527-2:2012.
    RESULTS: All 2-in-1 wet wipes tested contained ESC agents, although the severity of ESC varied. Products with higher pH (>8.0) were responsible for 74% of failures, with 22 of the 39 tested plastics visibly cracking. Although the primary active in all tested wipe formulations were quaternary ammonium compounds, formulations that included small/medium amines or alcohol demonstrated a greater propensity for plastic cracking.
    CONCLUSIONS: Each disinfectant formulation exhibits a unique spectrum of microbial efficacy and unique potential to cause surface damage. This may result in device failures and recalls that could compromise patient and staff safety. BS EN ISO-22088-3 can support material compatibility assessments of disinfectant and detergent products before they come to market.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目标:电子稳定控制系统(ESC)被认为是最有效的车辆安全干预措施之一,据报道,对致命的单次和翻车事故的影响约为50%。然而,这样的估计使用了样本数据,没有控制自我选择的可能性,行为适应,安全性较低的驾驶员增加了对该技术的访问,以及对非常特定类别的碰撞的影响的计算。因此,预期ESC在群体中的影响比目前认为的要小。
    方法:美国全国致命车祸数据,驾驶暴露和其他控制因素,和ESC在1991-2021年的市场渗透率被用来计算单身人士撞车率随时间的死亡趋势,侧翻,和致命的崩溃通常与有效性估计的预测相匹配。
    结果:发现在引入ESC之前,相关碰撞类型的下降趋势普遍存在,此后的趋势较弱。尽管一些趋势与ESC的影响一致,它们明显比预计的小,可以用其他因素来解释,例如人均车辆数量。充其量,展期的影响可能高达先前估计的三分之二,单身人士没有检测到效果,而对于所有致命的崩溃结果取决于所执行的分析类型。这些结果与所有已发表的ESC碰撞样本研究的结论相冲突,比较了有和没有ESC的车辆。这种差异可以通过先前使用诱导暴露方法和自我选择样品的研究中的方法学错误来解释。
    结论:技术干预可能不会像人们认为的那样大大改善交通安全。交通安全需要替代方法,不依赖于干扰驾驶员行为的技术。
    OBJECTIVE: Electronic Stability Control (ESC) is believed to be among the most efficient vehicle safety interventions with reported effects around 50% for fatal single and rollover crashes. However, such estimates have used sample data, which have not controlled for the possibilities of self-selection, behavioral adaptation, increased access to the technology by less safe drivers, and the calculation of effects on very specific categories of crashes. Effects of ESC in the population can therefore be expected to be smaller than is currently believed.
    METHODS: National U.S. data for fatal crashes, driving exposure and other control factors, and market penetration of ESC over 1991-2021 were used to calculate whether the trends in fatalities over time in crash rates for singles, rollovers, and fatal crashes in general matched projections from estimates of effectiveness.
    RESULTS: It was found that downward trends in the relevant crash types were generally present before ESC was introduced, and that the trends thereafter were weaker. Although some trends were consistent with effects of ESC, they were markedly smaller than the projected ones, and could be explained by other factors such as the number of vehicles per capita. At best, the effect for rollovers could be up to two-thirds of previous estimates, no effect was detected for singles, while for all fatal crashes results depended upon the type of analysis performed. These results conflict with conclusions in all published ESC crash sample studies, which have compared vehicles with and without ESC. This discrepancy can be explained by methodological errors in the previous studies using induced exposure methods and self-selected samples.
    CONCLUSIONS: Traffic safety may not be as much improved by technological interventions as believed. Alternative approaches to traffic safety are needed, which do not rely on technology that interferes with driver behavior.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Review
    背景:心力衰竭(HF)是住院最常见的心血管原因,尤其是60岁以上的患者。射血分数降低的心力衰竭(HFrEF)占所有心力衰竭病例的大约50%。家庭心脏康复(HBCR)是一种替代选择,可提高无法参加中心心脏康复(CBCR)的患者的心脏康复(CR)干预措施的参与率。这篇综述的目的是澄清目前HBCR研究与欧洲心脏病学会(ESC)和英国心脏预防和康复协会(BACPR)定义的核心组成部分的一致性程度。
    方法:通过四个数据库进行了严格审查,MEDLINE,Embase,Cochrane中央控制试验登记册,和Cochrane系统评价数据库,确定截至2022年6月的随机对照试验。我们仔细研究了BACPR和ESC之间的共性,并制定了一系列标准。使用RoB2工具评估偏倚风险。
    结果:在全文筛选的87篇论文中,11项研究符合纳入标准。六篇论文对基本标准具有很高的保真度,四项研究有一个中等联盟,一次干预的联盟水平很低。
    结论:总体而言,大多数纳入的研究与标准和核心组成部分具有中等到高度的一致性.然而,需要更多地关注长期战略作为一个重要标准。快速识别和初步评估是最符合的标准;然而,生活方式风险因素管理和长期结局被认为是最不符合的标准.
    Heart failure (HF) is the most common cardiovascular reason for hospital admission, particularly among patients older than 60 years old. Heart failure with reduced ejection fraction (HFrEF) comprises approximately 50% of all heart failure cases. Home-based cardiac rehabilitation (HBCR) is an alternative option to enhance the participation rate in cardiac rehabilitation (CR) interventions for patients who are not able to attend center-based cardiac rehabilitation (CBCR). The purpose of this review is to clarify the extent to which present studies of HBCR align with the core components defined by both the European Society of Cardiology (ESC) and the British Association for Cardiac Prevention and Rehabilitation (BACPR).
    A critical review was conducted through four databases, MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews, to identify randomized controlled trials up until June 2022. We scrutinized the commonalities between BACPR and ESC and developed a list of standards. The risk of bias was assessed using the RoB 2 tool.
    Among the 87 papers selected for full-text screening, 11 studies met the inclusion criteria. Six papers possessed a high proportion of fidelity to essential standards, four studies had a medium alliance, and one intervention had a low level of alliance.
    Overall, the majority of included studies had medium to high alignment with standards and core components. However, a need for more attention to long-term strategy as an important standard is revealed. Rapid identification and initial assessment are the most met standards; however, lifestyle risk factor management and long-term outcomes were recognized as the least met standards.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:总结在2023年欧洲心脏病学会(ESC)大会上发表的有关心血管(CV)疾病预防的最新科学。
    结果:NATURE-PARADOX是一项自然随机试验,使用UKBiobank注册的遗传数据创建“低密度脂蛋白胆固醇(LDL-C)累积暴露”生物标志物,并评估其与主要CV事件的关联,而与血浆LDL-C水平或年龄无关。inclisiran的安全性和有效性数据,PCSK9干扰mRNA(PCSK9i),每年两次皮下给药,被介绍了。提供了两个新的PCSK9is的数据,recaticimab,口服药物,还有Lerodalcibep,一种与目前可用的PSCK9is结构略有不同的皮下药物。关于穆瓦拉平的第一阶段试验,口服脂蛋白(a)抑制剂,被介绍了。提出了一种使用SCORE2数据的亚洲人群动脉粥样硬化CV疾病(ASCVD)风险预测算法。对参加CLEAR结局试验的患者进行的长期随访显示,在高危患者中,bempedoic酸可持续且更显著地降低ASCVD风险。ESC2023年大会的最新临床科学通过引入此类新药扩展了PCSK9i的已知安全性和有效性数据。使用累积暴露于LDL-C而不是单一值将有助于临床医生根据个人风险定制LDL-C降低策略,并且是迈向个性化医疗的重要一步。
    To summarize selected late-breaking science on cardiovascular (CV) disease prevention presented at the 2023 European Society of Cardiology (ESC) congress.
    The NATURE-PARADOX was a naturally randomized trial that used genetic data from the UK Biobank registry to create \"cumulative exposure to low-density lipoprotein-cholesterol (LDL-C)\" biomarker and evaluate its association with major CV events regardless of plasma LDL-C levels or age. Safety and efficacy data of inclisiran, a PCSK9-interfering mRNA (PCSK9i) administered subcutaneously twice annually, were presented. Data on two new PCSK9is were presented, recaticimab, an oral drug, and lerodalcibep, a subcutaneous drug with a slightly different architecture than currently available PSCK9is. A phase 1 trial on muvalaplin, an oral lipoprotein (a) inhibitor, was presented. An atherosclerotic CV disease (ASCVD) risk prediction algorithm for the Asian population using SCORE2 data was presented. Long-term follow-up of patients enrolled in the CLEAR outcomes trial showed sustained and more significant ASCVD risk reduction with bempedoic acid in high-risk patients. The late-breaking clinical science at the 2023 congress of the ESC extends the known safety and efficacy data of a PCSK9i with the introduction of new drugs in this class. Using cumulative exposure to LDL-C rather than a single value will help clinicians tailor the LDL-C reduction strategy to individual risk and is an important step towards personalized medicine.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在过去的十年中,心脏MRI取得了重大进展,成为评估各种心脏病变的重要技术。本文的目的是根据当前的STEMIESC指南,审查当前进行心脏MRI的适应症。NSTEMI,慢性冠状动脉疾病,心力衰竭,心律失常,心源性猝死,心脏瓣膜病,心包疾病和先天性心脏病。该综述讨论了cMR对许多心脏病的诊断和预后价值。及其在评估结构性心脏病和预测心律失常风险方面的重要价值。此外,它反映了准则的适当性,并指出了今后版本中应修改指示的领域,根据作者的个人意见。建议使用cMR的指导标准应更加明确,以促进其使用并导致更具体的偿还。然而,需要进一步的研究来更好地记录未来cMR的价值。
    Cardiac MRI has made significant advances in the past decade, becoming an important technique for the evaluation of various cardiac pathologies. The aim of this document is to review the current indications for performing cardiac MRI based on the current ESC guidelines for STEMI, NSTEMI, chronic coronary artery disease, heart failure, arrhythmias, sudden cardiac death, valvular heart disease, pericardial disease and congenital heart disease. The review discusses the diagnostic and prognostic value of cMR for numerous cardiac diseases, and its important value in assessing structural heart disease and predicting arrhythmia risk. Additionally, it reflects upon the appropriateness of the guidelines and points out areas where the indications should be revised in future editions, based on the author\'s personal opinion. It is suggested that guideline criteria for the use of cMR should be more explicit to promote its use and lead to more specific reimbursements. However, further studies are needed to even better document the value of cMR in the future.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在早期脊椎动物发育中,组织者区域-通过分泌的形态发生素向相邻细胞发出信号并由此影响相邻细胞的细胞群-在确定的组织区域内细胞身份的建立和维持中起关键作用。中脑-后脑组织者将神经组织区域化为中脑和后脑区域,成纤维细胞生长因子8(FGF8)作为关键形态发生原。这个组织者已经在鸡肉中进行了广泛的研究,鼠标,还有斑马鱼.这里,我们证明了从人类多能干细胞(hPSC)中富集表达FGF8的细胞,使用识别“与Fgf相似表达”(SEF)和Frizzled蛋白的抗体作为附着的胚状体进行培养。这些培养物的胚状体亚群中的细胞排列以及FGF8表达群体的基因表达谱显示出与动物模型中的中脑-后脑组织者的某些相似性。在胚胎小鸡的大脑中,富集的细胞群诱导中脑结构的形成,与FGF8组织能力一致。
    In early vertebrate development, organizer regions-groups of cells that signal to and thereby influence neighboring cells by secreted morphogens-play pivotal roles in the establishment and maintenance of cell identities within defined tissue territories. The midbrain-hindbrain organizer drives regionalization of neural tissue into midbrain and hindbrain territories with fibroblast growth factor 8 (FGF8) acting as a key morphogen. This organizer has been extensively studied in chicken, mouse, and zebrafish. Here, we demonstrate the enrichment of FGF8-expressing cells from human pluripotent stem cells (hPSCs), cultured as attached embryoid bodies using antibodies that recognize \"Similar Expression to Fgf\" (SEF) and Frizzled proteins. The arrangement of cells in embryoid body subsets of these cultures and the gene expression profile of the FGF8-expressing population show certain similarities to the midbrain-hindbrain organizer in animal models. In the embryonic chick brain, the enriched cell population induces formation of midbrain structures, consistent with FGF8-organizing capability.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号